Notable New Meds of 2024
Course #25-622 -
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
In this podcast, listen in as our editors discuss several novel drugs approved in 2024 and highlight some medications now available in a new dosage form. They'll review efficacy, safety, and considerations for use with these new treatment options.
This course is designed for pharmacy professionals, physicians, PAs, and nurses in all practice settings.
The purpose of this course is to provide healthcare providers with up-to-date and relevant information related to medication therapy, practice, and patient care in order improve their practices and patient outcomes.
Upon completion of this course, you should be able to:
- Identify emerging trends in drug therapy and their place in patient care practices.
- Summarize 3 novel drugs approved in 2024.
- Discuss characteristics of 3 new medication dosage forms approved in 2024.
Sara Klockars, PharmD, BCPS, is an Associate Editor at Prescriber Insights and Pharmacist’s Letter. She earned her PharmD degree from Ohio Northern University. She then completed two years of clinical pharmacy residency at the Medical University of South Carolina. Prior to coming to Prescriber Insights and Pharmacist’s Letter in 2019, Sara was a Clinical Pharmacy Specialist at Kaiser Permanente Colorado working alongside prescribers and pharmacists in an integrated healthcare system. She spent 12 years as part of the Primary Care team and built a practice in Dermatology, where she practiced for 4 years prior to joining TRC. In addition to dermatology, Sara’s professional interests include pharmacist and prescriber education, promoting evidence-based, cost-effective care, and other specialty pharmacy areas (rheumatology, gastroenterology, etc.).
Stephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC,
Contributing faculty, Sara Klockars, PharmD, BCPS, has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
Contributing faculty, Stephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC, has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
Flora Harp, PharmD
The division planner has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
Sarah Campbell
The Director of Development and Academic Affairs has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
The purpose of NetCE is to provide challenging curricula to assist healthcare professionals to raise their levels of expertise while fulfilling their continuing education requirements, thereby improving the quality of healthcare.
Our contributing faculty members have taken care to ensure that the information and recommendations are accurate and compatible with the standards generally accepted at the time of publication. The publisher disclaims any liability, loss or damage incurred as a consequence, directly or indirectly, of the use and application of any of the contents. Participants are cautioned about the potential risk of using limited knowledge when integrating new techniques into practice.
It is the policy of NetCE not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.
Supported browsers for Windows include Microsoft Internet Explorer 9.0 and up, Mozilla Firefox 3.0 and up, Opera 9.0 and up, and Google Chrome. Supported browsers for Macintosh include Safari, Mozilla Firefox 3.0 and up, Opera 9.0 and up, and Google Chrome. Other operating systems and browsers that include complete implementations of ECMAScript edition 3 and CSS 2.0 may work, but are not supported. Supported browsers must utilize the TLS encryption protocol v1.1 or v1.2 in order to connect to pages that require a secured HTTPS connection. TLS v1.0 is not supported.
The role of implicit biases on healthcare outcomes has become a concern, as there is some evidence that implicit biases contribute to health disparities, professionals' attitudes toward and interactions with patients, quality of care, diagnoses, and treatment decisions. This may produce differences in help-seeking, diagnoses, and ultimately treatments and interventions. Implicit biases may also unwittingly produce professional behaviors, attitudes, and interactions that reduce patients' trust and comfort with their provider, leading to earlier termination of visits and/or reduced adherence and follow-up. Disadvantaged groups are marginalized in the healthcare system and vulnerable on multiple levels; health professionals' implicit biases can further exacerbate these existing disadvantages.
Interventions or strategies designed to reduce implicit bias may be categorized as change-based or control-based. Change-based interventions focus on reducing or changing cognitive associations underlying implicit biases. These interventions might include challenging stereotypes. Conversely, control-based interventions involve reducing the effects of the implicit bias on the individual's behaviors. These strategies include increasing awareness of biased thoughts and responses. The two types of interventions are not mutually exclusive and may be used synergistically.